Small Cell Lung Cancer, Polygonal Type
1 clinical trials · Condition
◉ Watch Small Cell Lung Cancer, Polygonal Type
| Record | Firm | Date |
|---|---|---|
| PD-L1 and Other Immuno-markers Influenced by Osimertinib Treatment in Advanced NSCLC Patients (NCT03029858) | Guangdong Association of Clinical Trials | 2017-01-01 |
Track Small Cell Lung Cancer, Polygonal Type automatically
Every clearance here is in the API, with alerts when new ones post.